ARCHIVES

As Leadership Changes Continue, Fontaine, Leach Get New Posts

This article is from The Cancer Letter archive.

Vol. 40 No. 03 | January 17, 2014

Download PDF Visit The Full Archive

Related Articles

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Soviet Exchanges Rise And Fall With Politics

August 23, 1991

House Approves 1.9 Percent Increase For NIH.

July 20, 2007